Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
395.80
+3.10 (0.79%)
Jul 9, 2025, 4:38 PM IDT

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of 93.82 million as of July 9, 2025. Its market cap has decreased by -6.33% in one year.

Market Cap
93.82M
Enterprise Value
26.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
395.80

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 93.82M, a decrease of -74.51%. That is a compound annual growth rate of -19.54%.

History

DateMarket Cap% Change
Jul 7, 202595.97M2.41%
Dec 31, 202493.71M-48.18%
Dec 29, 2023180.84M-29.06%
Dec 30, 2022254.92M-28.46%
Dec 31, 2021356.33M-8.65%
Dec 31, 2020390.07M30.23%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 65.07B
Danel (Adir Yeoshua) 2.90B
Kamada 1.51B
Bait Bakfar 1.10B
BrainsWay 854.16M
SofWave Medical 819.21M
Ilex Medical 723.42M
Novolog (Pharm-Up 1966) 696.79M
Market Cap Rankings